Evidence map›Paper›PMID 27835727›Full record

ArticleThe primary care companion for CNS disorders2016

Psychoactive Substance Use by Adults With Schizophrenia Before and During Cannabis Withdrawal.

Maju Mathew Koola, Deanna L Kelly, Robert P McMahon, Douglas L Boggs, Fang Liu, David A Gorelick

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The primary care companion for CNS disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maju Mathew KoolaClinical Research Program, Sheppard Pratt Health System, Baltimore, Maryland, and Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Deanna L KellyMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Robert P McMahonMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Douglas L BoggsVeterans Affairs Connecticut Healthcare System, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Fang LiuMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
David A Gorelickdgorelick@mprc.umaryland.edu.

Funding

Multidisciplinary Schizophrenia Research TrainingT32MH067533 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CARPENTER, WILLIAM T., ELMER, GREGORY I · 2004 to 2025
$4.3M
Comorbid Substance Abuse and Long-Term Health Outcomes in SchizophreniaR03MH076985 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI KELLY, DEANNA L · 2007 to 2008
$150k
NIDA NIH HHS N01 DA059909NIMH NIH HHS R03 MH076985NIMH NIH HHS T32 MH067533
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Schizophrenic PsychologyAdultHumansMarijuana AbuseMiddle AgedPsychotropic DrugsSchizophreniaSubstance Withdrawal SyndromeYoung AdultPsychotropic Drugs

Identifiers

PMID27835727
PMCPMC5878014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.